SanBio Company Limited provided consolidated earnings guidance for the first half of fiscal year ending January 31, 2025, and full fiscal year ending January 31, 2025. For the first half period, the company expects to report operating loss of JPY 1,414 million, net loss attributable to the owners of parent of JPY 1,425 million, and net loss per share of JPY 20.98.

For the full year period, the company expects to report operating loss of JPY 3,339 million, net loss attributable to the owners of parent of JPY 3,359 million, and net loss per share of JPY 49.45.